Affini-T Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Affini-T Therapeutics's estimated annual revenue is currently $21.4M per year.
- Affini-T Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Affini-T Therapeutics has 138 Employees.
- Affini-T Therapeutics grew their employee count by 33% last year.
Affini-T Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | COO | Reveal Email/Phone |
3 | CTO | Reveal Email/Phone |
4 | Chief Business Officer | Reveal Email/Phone |
5 | Head Gene Editing | Reveal Email/Phone |
6 | VP Precision and Translational Medicine | Reveal Email/Phone |
7 | VP Business Development and Alliance Management | Reveal Email/Phone |
8 | Head Quality | Reveal Email/Phone |
9 | Head Gene Editing | Reveal Email/Phone |
10 | VP Finance and Chief Accounting Officer | Reveal Email/Phone |
Affini-T Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Affini-T Therapeutics?
Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop potentially curative therapies for solid tumor cancers. Our differentiated cell therapy platform harnesses state-of-the-art engineering, and synthetic biology capabilities to target even the most devastating cancer-driving mutations, beginning with KRAS. We leverage these tools to optimize T-cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. Building on the world-class innovation inherent in our leadership team, founders and technologies, we are powered to develop transformational medicines that last.
keywords:N/A
N/A
Total Funding
138
Number of Employees
$21.4M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.3M | 138 | 34% | N/A |
#2 | $42.1M | 138 | 5% | N/A |
#3 | $40M | 138 | 16% | N/A |
#4 | $22.5M | 138 | 10% | N/A |
#5 | $37.3M | 138 | 42% | N/A |